Vitamin D in exercise: Physiologic and analytical concerns

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 45-53

  Lanteri, Patrizia ^a   Lombardi, Giovanni ^a   Colombini, Alessandra ^a   Banfi, Giuseppe ^a,b  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Athletes; Physical performance; Supplementation; Vitamin D status

Indexed keywords

1,25 HYDROXYVITAMIN D3 24 HYDROXYLASE; CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D;

ADVERSE OUTCOME; ATHLETE; BONE DENSITY; ENZYME ACTIVITY; EXERCISE; HEALTH STATUS; HEART FUNCTION; HUMAN; HYPERCALCEMIA; MUSCLE CONTRACTION; MUSCLE STRENGTH; NONHUMAN; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; SPORTS MEDICINE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ATHLETES; DIETARY SUPPLEMENTS; EXERCISE; FEMALE; HUMANS; MALE; PHYSICAL ENDURANCE; SKIN; SKIN PIGMENTATION; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84870358545     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.004     Document Type: Review

References (112)

1. Heaney R.P., Recker R.R., Grote J., Horst R.L., Armas L.A. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011, 96:E447-E452.
2. Holick M.F., Biancuzzo R.M., Chen T.C., et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
3. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79:362-371.
4. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005, 289:F8-F28.
5. Bartoszewska M., Kamboj M., Patel D.R. Vitamin D, muscle function, and exercise performance. Pediatr Clin North Am 2010, 57:849-861.
6. Holick M.F. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981, 77:51-58.
7. Aloia J.F. Clinical review: the 2011 report on dietary reference intake for vitamin D: where do we go from here?. J Clin Endocrinol Metab 2011, 96:2987-2996.
8. Holick M.F., Siris E.S., Binkley N., et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215-3224.
9. Aloia J.F., Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007, 135:1095-1096. [author reply 1097-1098].
10. Dittmer K.E., Thompson K.G. Vitamin D metabolism and rickets in domestic animals: a review. Vet Pathol 2011, 48:389-407.
11. Pfeifer M., Begerow B., Minne H.W. Vitamin D and muscle function. Osteoporos Int 2002, 13:187-194.
12. Cannell J.J., Hollis B.W., Sorenson M.B., Taft T.N., Anderson J.J. Athletic performance and vitamin D. Med Sci Sports Exerc 2009, 41:1102-1110.
13. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
14. Christakos S., Ajibade D.V., Dhawan P., Fechner A.J., Mady L.J. Vitamin D: metabolism. Endocrinol Metab Clin North Am 2010, 39:243-253. [table of contents].
15. Omdahl J.L., Morris H.A., May B.K. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002, 22:139-166.
16. Henry H.L. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011, 25:531-541.
17. Swamy N., Head J.F., Weitz D., Ray R. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein. Arch Biochem Biophys 2002, 402:14-23.
18. Goldschmidt-Clermont P.J., Van Alstyne E.L., Day J.R., et al. Group-specific component (vitamin D binding protein) prevents the interaction between G-actin and profilin. Biochemistry 1986, 25:6467-6472.
19. Chishimba L., Thickett D.R., Stockley R.A., Wood A.M. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 2010, 65:456-462.
20. Chun R.F., Adams J.S., Hewison M. Back to the future: a new look at 'old' vitamin D. J Endocrinol 2008, 198:261-269.
21. Nykjaer A., Dragun D., Walther D., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999, 96:507-515.
22. Nykjaer A., Fyfe J.C., Kozyraki R., et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci U S A 2001, 98:13895-13900.
23. Delmez J.A., Slatopolsky E., Martin K.J., Gearing B.N., Harter H.R. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 1982, 21:862-867.
24. Katikaneni L.P., Emerson D.L., Goldschmidt-Clermont P.J., Loadholt B.C., Levkoff A.H., Galbraith R.M. High levels of group-specific component (vitamin-D-binding protein) in the cerebrospinal fluid of infants aged less than 2months. Biol Neonate 1987, 52:250-255.
25. Kew R.R., Sibug M.A., Liuzzo J.P., Webster R.O. Localization and quantitation of the vitamin D binding protein (Gc-globulin) in human neutrophils. Blood 1993, 82:274-283.
26. Sabbatini A., Petrini M., Mattii L., Arnaud P., Galbraith R.M. Vitamin D binding protein is produced by human monocytes. FEBS Lett 1993, 323:89-92.
27. Kim M.S., Fujiki R., Kitagawa H., Kato S. 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 2007, 265-266:168-173.
28. Bai X.Y., Miao D., Goltzman D., Karaplis A.C. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 2003, 278:9843-9849.
29. Henry H.L. The 25(OH)D(3)/1alpha,25(OH)(2)D(3)-24R-hydroxylase: a catabolic or biosynthetic enzyme?. Steroids 2001, 66:391-398.
30. Schwartz Z., Bonewald L.F., Caulfield K., Brooks B., Boyan B.D. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. Endocrinology 1993, 132:1544-1552.
31. Colombini A., Lanteri P., Lombardi G., et al. Metabolic effects of vitamin D active metabolites in monolayer and micromass cultures of nucleus pulposus and annulus fibrosus cells isolated from human intervertebral disc. Int J Biochem Cell Biol 2012, 44:1019-1030.
32. Mason R.S., Sequeira V.B., Gordon-Thomson C. Vitamin D: the light side of sunshine. Eur J Clin Nutr 2011, 65:986-993.
33. Jesudason D., Need A.G., Horowitz M., O'Loughlin P.D., Morris H.A., Nordin B.E. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002, 31:626-630.
34. Prentice A., Goldberg G.R., Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008, 88:500S-506S.
35. Lieben L., Carmeliet G., Masuyama R. Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract Res Clin Endocrinol Metab 2011, 25:561-572.
36. Haussler M.R., Jurutka P.W., Mizwicki M., Norman A.W. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)vitamin D: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011, 25:543-559.
37. Norman A.W., Okamura W.H., Hammond M.W., et al. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Mol Endocrinol 1997, 11:1518-1531.
38. Norman A.W., Bouillon R., Farach-Carson M.C., et al. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J Biol Chem 1993, 268:20022-20030.
39. Kajikawa M., Ishida H., Fujimoto S., et al. An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology 1999, 140:4706-4712.
40. Rebsamen M.C., Sun J., Norman A.W., Liao J.K. 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 2002, 91:17-24.
41. Zanello L.P., Norman A.W. Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci U S A 2004, 101:1589-1594.
42. Menegaz D., Barrientos-Duran A., Kline A., et al. 1alpha,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. J Steroid Biochem Mol Biol 2010, 119:127-134.
43. Mizwicki M.T., Bula C.M., Mahinthichaichan P., Henry H.L., Ishizuka S., Norman A.W. On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist. J Biol Chem 2009, 284:36292-36301.
44. Bula C.M., Huhtakangas J., Olivera C., Bishop J.E., Norman A.W., Henry H.L. Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 2005, 146:5581-5586.
45. Huhtakangas J.A., Olivera C.J., Bishop J.E., Zanello L.P., Norman A.W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 2004, 18:2660-2671.
46. Larson-Meyer D.E., Willis K.S. Vitamin D and athletes. Curr Sports Med Rep 2010, 9:220-226.
47. Halliday T.M., Peterson N.J., Thomas J.J., Kleppinger K., Hollis B.W., Larson-Meyer D.E. Vitamin D status relative to diet, lifestyle, injury, and illness in college athletes. Med Sci Sports Exerc 2011, 43:335-343.
48. Hamilton B., Grantham J., Racinais S., Chalabi H. Vitamin D deficiency is endemic in Middle Eastern sportsmen. Public Health Nutr 2010, 13:1528-1534.
49. Lovell G. Vitamin D status of females in an elite gymnastics program. Clin J Sport Med 2008, 18:159-161.
50. van Schoor N.M., Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011, 25:671-680.
51. Lehtonen-Veromaa M., Mottonen T., Irjala K., et al. Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr 1999, 53:746-751.
52. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J.A., Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987, 64:1165-1168.
53. Constantini N.W., Arieli R., Chodick G., Dubnov-Raz G. High prevalence of vitamin D insufficiency in athletes and dancers. Clin J Sport Med 2010, 20:368-371.
54. Lombardi G., Colombini A., Freschi M., Tavana R., Banfi G. Seasonal variation of bone turnover markers in top-level female skiers. Eur J Appl Physiol 2011, 111:433-440.
55. Maimoun L., Manetta J., Couret I., et al. The intensity level of physical exercise and the bone metabolism response. Int J Sports Med 2006, 27:105-111.
56. Boxer R.S., Dauser D.A., Walsh S.J., Hager W.D., Kenny A.M. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008, 56:454-461.
57. Snijder M.B., van Schoor N.M., Pluijm S.M., van Dam R.M., Visser M., Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006, 91:2980-2985.
58. Holick M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19:73-78.
59. Heaney R.P. Assessing vitamin D status. Curr Opin Clin Nutr Metab Care 2011, 14:440-444.
60. Banfi G., Lombardi G., Colombini A., Lippi G. Bone metabolism markers in sports medicine. Sports Med 2010, 697-714.
61. Hill T.R., McCarthy D., Jakobsen J., Lamberg-Allardt C., Kiely M., Cashman K.D. Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res 2007, 77:320-325.
62. Lips P., van Schoor N.M. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011, 25:585-591.
63. Burgi A.A., Gorham E.D., Garland C.F., et al. High serum 25-hydroxyvitamin D is associated with a low incidence of stress fractures. J Bone Miner Res 2011, 26:2371-2377.
64. Norman A.W., Nemere I., Zhou L.X., et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992, 41:231-240.
65. Dirks-Naylor A.J., Lennon-Edwards S. The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol 2011, 125:159-168.
66. Hamilton B. Vitamin D and athletic performance: the potential role of muscle. Asian J Sports Med 2011, 2:211-219.
67. Zittermann A., Sabatschus O., Jantzen S., et al. Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels compared with age-matched sedentary controls. Calcif Tissue Int 2000, 67:215-219.
68. Bell N.H., Godsen R.N., Henry D.P., Shary J., Epstein S. The effects of muscle-building exercise on vitamin D and mineral metabolism. J Bone Miner Res 1988, 3:369-373.
69. Allen R.M., Cureton T.K. Effect of ultraviolet radiation on physical fitness. Arch Phys Med Rehabil 1945, 26:641-644.
70. Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Korfer R., Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 2003, 41:105-112.
71. Zittermann A., Schleithoff S.S., Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it?. Heart Fail Rev 2006, 11:25-33.
72. Pilz S., Tomaschitz A., Drechsler C., Dekker J.M., Marz W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010, 54:1103-1113.
73. Pencina M.J., Vasan R.S., D'Agostino R.B. Algorithms for assessing cardiovascular risk in women. JAMA 2007, 298:175-176. [author reply 177-178].
74. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
75. Manson J.E., Mayne S.T., Clinton S.K. Vitamin D and prevention of cancer-ready for prime time?. N Engl J Med 2011, 364:1385-1387.
76. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
77. Ross A.C., Abrams S.A., Aloia A., et al. Dietary Reference Intakes for Calcium and Vitamin D 2010, 2012.
78. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
79. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010, 340:b5500.
80. Bischoff-Ferrari H. Health effects of vitamin D. Dermatol Ther 2010, 23:23-30.
81. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83:754-759.
82. Pfeifer M., Begerow B., Minne H.W., Abrams C., Nachtigall D., Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000, 15:1113-1118.
83. Broe K.E., Chen T.C., Weinberg J., Bischoff-Ferrari H.A., Holick M.F., Kiel D.P. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007, 55:234-239.
84. Pfeifer M., Begerow B., Minne H.W., Suppan K., Fahrleitner-Pammer A., Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009, 20:315-322.
85. Boullata J.I. Vitamin D supplementation: a pharmacologic perspective. Curr Opin Clin Nutr Metab Care 2010, 13:677-684.
86. Aloia J.F., Patel M., Dimaano R., et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008, 87:1952-1958.
87. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.
88. Mastaglia S.R., Mautalen C.A., Parisi M.S., Oliveri B. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr 2006, 60:681-687.
89. Tjellesen L., Hummer L., Christiansen C., Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986, 1:407-413.
90. Trang H.M., Cole D.E., Rubin L.A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
91. Harris S.S., Dawson-Hughes B. Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr 2002, 21:357-362.
92. Khazai N.B., Judd S.E., Jeng L., et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab 2009, 94:2037-2043.
93. Holvik K., Madar A.A., Meyer H.E., Lofthus C.M., Stene L.C. A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4weeks of daily oral intake of 10microg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults. Br J Nutr 2007, 98:620-625.
94. Willis K.S., Peterson N.J., Larson-Meyer D.E. Should we be concerned about the vitamin D status of athletes?. Int J Sport Nutr Exerc Metab 2008, 18:204-224.
95. Nieves J.W., Melsop K., Curtis M., et al. Nutritional factors that influence change in bone density and stress fracture risk among young female cross-country runners. PM R 2010, 2:740-750. [quiz 794].
96. Williams M.H. Vitamin supplementation and athletic performance. Int J Vitam Nutr Res Suppl 1989, 30:163-191.
97. Powers S., Nelson W.B., Larson-Meyer E. Antioxidant and Vitamin D supplements for athletes: sense or nonsense?. J Sports Sci 2011, 29(Suppl. 1):S47-S55.
98. Heaney R.P. Vitamin D: criteria for safety and efficacy. Nutr Rev 2008, 66:S178-S181.
99. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008, 88:582S-586S.
100. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007, 85:6-18.
101. Kimball S.M., Ursell M.R., O'Connor P., Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 2007, 86:645-651.
102. Carter G.D., Carter C.R., Gunter E., et al. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004, 89-90:467-471.
103. Lai J.K., Lucas R.M., Clements M.S., Harrison S.L., Banks E. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010, 54:1062-1071.
104. Hollis B.W., Kamerud J.Q., Selvaag S.R., Lorenz J.D., Napoli J.L. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993, 39:529-533.
105. Carter G.D., Jones J.C., Berry J.L. The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol 2007, 103:480-482.
106. Carter G.D. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009, 55:1300-1302.
107. Hollis B.W. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 2000, 46:1657-1661.
108. Zerwekh J.E. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008, 87:1087S-1091S.
109. Hollis B.W., Horst R.L. The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going. J Steroid Biochem Mol Biol 2007, 103:473-476.
110. Hollis B.W., Kamerud J.Q., Kurkowski A., Beaulieu J., Napoli J.L. Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem 1996, 42:586-592.
111. Koutkia P., Chen T.C., Holick M.F. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001, 345:66-67.
112. Titan S.M., Callas S.H., Uip D.E., Kalil-Filho R., A Galvão P.C. Acute renal failure and hypercalcemia in an athletic young man. Clin Nephrol 2009, 71:445-447.